BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Cycloartanol | Cycloartanol is a natural triterpenoid compound found in the fruits of Citrus medica. Group: Pharmaceutical. CAS No. 4657-58-3. Pack Sizes: 1 mg. Product ID: NP6361. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Cycloastragenol | Cycloastragenol, belongs to the triterpene saponins, is mainly obtained from the hydrolysis of Astragaloside IV. Cycloastradiol is the only telomerase activator found today. It delays the shortening of telomeres by increasing telomerase. Cycloastradiol is believed to have anti-aging effects. Cycloastragenol can be used in cosmetics material. Group: Pharmaceutical. CAS No. 78574-94-4. Pack Sizes: 50 mg. Product ID: NP6270. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclobenzaprine Impurities | Cyclobenzaprine Impurities are crucial in analyzing and determining the purity of cyclobenzaprine, a muscle relaxant used to relieve muscle spasms associated with acute musculoskeletal conditions. These impurities are instrumental in quality control and drug formulation to ensure safety and efficacy in therapeutic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclocephaloside II | Cyclocephaloside II - a natural remedy with immense potential for use in treating Alzheimer's disease. Its efficacy lies in its role as an effective inhibitor of amyloid beta peptides. These peptides are widely believed to play a pivotal part in the neural degradation characteristic of Alzheimer's disease. In addition, studies have indicated that Cyclocephaloside II possesses antioxidant and anti-inflammatory properties, which may grant it protective effects against the ravages of oxidative stress within the brain. Group: Pharmaceutical. CAS No. 215776-78-6. Pack Sizes: 5 mg. Product ID: B0005-465738. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclogrifolin | Cyclogrifolin is a natural compound isolated from the fresh fruiting bodies of Albatrellus confluens. Group: Pharmaceutical. CAS No. 1660156-04-6. Pack Sizes: 1 mg. Product ID: NP5077. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cycloguanil hydrochloride | Cycloguanil is an active metabolite of proguanil, produced by the cytochrome P450 2C19 isoform. It is also an inhibitor of dihydrofolate reductase (DHFR) (Kis = 0.3 and 1.5 nM for Plasmodium and human forms, respectively). Uses: Antimalarials. Group: Pharmaceutical. CAS No. 152-53-4. Pack Sizes: 500 mg. Product ID: B2693-118548. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclohexadecanone | Cyclohexadecanone (CAS# 2550-52-9 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 2550-52-9. Pack Sizes: 500 mg. Product ID: B2699-205807. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclohexanedione Impurities | Cyclohexanedione Impurities, prevalent in synthetic organic chemistry, are vital to the biomedical realm for evaluating drug purity and safety. These impurities can influence the pharmacological profile of cyclohexanedione derivatives used in the treatment of neurological disorders and diabetes, contributing to a better understanding of pharmaceutical formulation and efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclo(L-Ala-L-Pro) | Cyclo(L-Ala-L-Pro) is a cyclodipeptide found in Phellinus igniarius. Cyclo(L-Ala-L-Pro) exhibits an inhibitory effect on Aflatoxin Production of Aspergillus flavus. Group: Pharmaceutical. CAS No. 36357-32-1. Pack Sizes: 10 mg. Product ID: BBF-04407. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclo(L-Leu-L-Pro) | Cyclo (-Leu-Pro) is a cyclic dipeptide containing leucine and proline. Group: Pharmaceutical. CAS No. 2873-36-1. Pack Sizes: 1 g. Product ID: BAT-010167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclomorusin | Cyclomorusin is a natural flavonoid found in the root bark of Morus alba L. Group: Pharmaceutical. CAS No. 62596-34-3. Pack Sizes: 1 mg. Product ID: NP2293. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cycloolivil | Cycloolivil isolated from the herbs of Maytenus hookeri Loes. Uses: Antioxidant. Group: Pharmaceutical. CAS No. 3064-5-9. Pack Sizes: 5 mg. Product ID: NP4107. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclopamine | Cyclopamine (11-deoxojervine) is a naturally occurring chemical that belongs to the group of steroidal jerveratrum alkaloids. It is a teratogen isolated from the corn lily (Veratrum californicum) that causes usually fatal birth defects. It can prevent the fetal brain from dividing into two lobes (holoprosencephaly) and cause the development of a single eye (cyclopia). It does so by inhibiting the hedgehog signaling pathway (Hh). Cyclopamine is useful in studying the role of Hh in normal development, and as a potential treatment for certain cancers in which Hh is overexpressed. Group: Pharmaceutical. CAS No. 4449-51-8. Pack Sizes: 100 mg. Product ID: BBF-03880. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclopamine Impurities | Cyclopamine Impurities serve a fundamental role in biomedical exploration, crucial for deciphering cancer-associated signaling pathways. These impurities facilitate the development of therapeutic agents targeting the Hedgehog signaling cascade, primarily implicated in basal cell carcinoma and medulloblastoma treatment, significantly advancing oncological therapy research. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclopentakis(1,4-butylene Terephthalate) | Cyclopentakis(1,4-butylene Terephthalate). Group: Pharmaceutical. CAS No. 82298-33-7. Pack Sizes: 10 mg. Product ID: B2699-346650. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclopentanol, 2-cyclopentylidene- | Cyclopentanol, 2-cyclopentylidene- is a useful research chemical. Group: Pharmaceutical. CAS No. 6261-30-9. Pack Sizes: 1 g. Product ID: B1370-145718. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclophosphamide Impurities | Cyclophosphamide Impurities, vital analytical constituents, are integral in the biomedical sector for assessing cyclophosphamide's purity and safetya renowned chemotherapeutic drug. Their surveillance is crucial to maintaining therapeutic effectiveness and reducing adverse reactions in oncological treatments, notably in lymphomas and leukemias, thereby enhancing clinical outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclophosphamide monohydrate | Cyclophosphamide monohydrate is a nitrogen mustard alkylating agent, which attaches the alkyl group to the guanine base of DNA. It is used to treat cancers and autoimmune diseases. Group: Pharmaceutical. CAS No. 6055-19-2. Pack Sizes: 25 g. Product ID: B0046-464089. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclopropanol | Cyclopropanol is a basic building block. Group: Pharmaceutical. CAS No. 16545-68-9. Pack Sizes: 50 g. Product ID: BB012189. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclo(Pro-Trp) | Cyclo(Pro-Trp). Group: Pharmaceutical. CAS No. 67889-75-2. Pack Sizes: 5 mg. Product ID: BAT-006245. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclo(RGDyK) Trifluoroacetate | Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM. Group: Pharmaceutical. CAS No. 250612-42-1. Pack Sizes: 100 mg. Product ID: BAT-010216. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporin A | Cyclosporin A (Cyclosporine A) is an immunosuppressant that binds to cyclophilins, inhibiting calcineurin activity with an IC50 of 7 nM. It also inhibits CD11a/CD18 adhesion molecules. Group: Pharmaceutical. CAS No. 59865-13-3. Pack Sizes: 5 g. Product ID: BAT-010028. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporin B | Cyclosporin B is a minor analogue of the cyclosporin complex produced by Trichoderma. An immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection. Group: Pharmaceutical. CAS No. 63775-95-1. Pack Sizes: 10 mg. Product ID: BBF-05762. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporin C | A minor analogue of the cyclosporin complex produced by a number of fungal species, including trichoderma, tolypocladium, fusarium, nectria and acremonium. It has the immunosuppressant activity but has been much less extensively investigated than the major analogue, cyclosporin A. Cyclosporin C is a broad-spectrum antifungal agent against filamentous phytopathogenic fungi but no activity against bacteria or yeasts. Group: Pharmaceutical. CAS No. 59787-61-0. Pack Sizes: 20 mg. Product ID: BBF-05763. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporin D | Cyclosporin D is a group of nonpolar cyclic oligopeptides with immunosupppressant activity. Cyclosporin D is a minor analogue of the cyclosporin complex produced by Trichoderma. Group: Pharmaceutical. CAS No. 63775-96-2. Pack Sizes: 10 mg. Product ID: BBF-05753. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporine EP Impurity B | Cyclosporine EP Impurity B is a closely related co-metabolite of cyclosporin A. It has no immunosuppressive activity and has been used as a control to determine the role of immunosuppression in cyclosporin A pharmacology, especially in the treatment of parasitic infections. Group: Pharmaceutical. CAS No. 59865-15-5. Pack Sizes: 25 mg. Product ID: BBF-05757. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporine EP Impurity C | A rearranged degradation product formed by acid treatment of cyclosporin A under aqueous and non-aqueous conditions. Group: Pharmaceutical. CAS No. 59865-16-6. Pack Sizes: 10 mg. Product ID: BBF-05766. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporine Impurities | Cyclosporine Impurities hold paramount significance within pharmaceutical quality assurance, particularly for cyclosporinea key immunosuppressant in transplantation and autoimmune therapies. They illuminate drug safety and effectiveness, elucidating stability profiles, degradation mechanisms, and possible toxicological impacts, thereby underpinning the advancement of more refined and secure therapeutic formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporin H | The minor analogues of the cyclosporin family have immunological activity because they do not bind to immunophilins. It is an inhibitor of phorbol ester that effectively promotes tumors on mouse skin, and effectively inhibits calcium/calmodulin-dependent phosphorylation of EF-2 in vitro. It is an effective and selective formyl peptide receptor antagonist and formyl peptide-induced superoxide formation inhibitor. Group: Pharmaceutical. CAS No. 83602-39-5. Pack Sizes: 10 mg. Product ID: BBF-05764. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclosporin Impurity 4 | Cyclosporin Impurity 4 is an impurity of cyclosporin, which is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation. Group: Pharmaceutical. CAS No. 59865-23-5. Pack Sizes: 5 mg. Product ID: BBF-05747. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclotetrakis(1,4-butylene Terephthalate) | Cyclotetrakis(1,4-butylene terephthalate), an innovative biocompatible polyester, holds immense potential for medical applications, including drug delivery and tissue engineering. Its biodegradability and non-toxicity have shown promise as a robust material for biomedical purposes. Nonetheless, its full therapeutic potency requires extensive research and evaluation. Group: Pharmaceutical. CAS No. 29278-72-6. Pack Sizes: 10 mg. Product ID: B2699-346649. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclotris(1,4-butylene Terephthalate) | Cyclotris(1,4-butylene terephthalate) is a polymer which demonstrates promise for use in sophisticated bio-applications e.g. drug delivery systems and tissue engineering. Exhibiting favorable biocompatibility properties, it may be utilized for encapsulating medication and providing targeted release to precise physiological areas. In addition to this, researchers have explored its potential in cardiovascular disease treatments; it may also be employed as a scaffold for regenerating tissue. Group: Pharmaceutical. CAS No. 63440-94-8. Pack Sizes: 10 mg. Product ID: B2699-346648. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclovirobuxine D | Cyclovirobuxine D is an active compound extracted from Buxus microphylla, which has been used for treating acute myocardial ischemia. Cyclovirobuxine D induces autophagy and attenuates the phosphorylation of Akt and mTOR. Cyclovirobuxine D inhibits cell proliferation of gastric cancer cells through suppression of cell cycle progression and inducement of mitochondria-mediated apoptosis. Uses: Anti- oxidative/anticancer. Group: Pharmaceutical. CAS No. 860-79-7. Pack Sizes: 100 mg. Product ID: B2703-351077. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyflumetofen | Cyflumetofen is a pesticide that was developed as an acaricide to control spider mites. Group: Pharmaceutical. CAS No. 400882-07-7. Pack Sizes: 100 mg. Product ID: B0046-141479. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CYN 154806 | CYN 154806 has been found to be a somatostatin sst2 receptor antagonist. Group: Pharmaceutical. CAS No. 183658-72-2. Pack Sizes: 5 mg. Product ID: BAT-006162. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cynarin | Cynarin, phenolic compound, is an antichoke agent with a variety of biological activities including antioxidant, antihistamic and antiviral activities. Cynarin is used in weight loss and lipid-lowering formulas, liver protection and anti-alcoholic drugs, etc. Group: Pharmaceutical. CAS No. 30964-13-7. Pack Sizes: 25 mg. Product ID: B2703-007275. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cynaropikrin | Cynaropikrin, a polyphenolic compound, is a sesquiterpene lactone in C. scolymus. Cynaropikrin is the bitter principle in artichoke and is, therefore, an important compound in the chemical profiling of the plant. Cynara scolymus L. (Asteraceae), commonly found in southern Europe and the USA, is cultivated as a vegetable and medicinal plant artichoke leaves are traditionally used for treatment of bile and liver diseases. Pharmacological studies have shown that extracts of the plant significantly increase choleresis (C. scolymus is used for treatment of dyspeptic syndrome) and reduce blood cholesterol, mainly because of inhibition of hepatocellular de novo cholesterol biosynthesis. Group: Pharmaceutical. CAS No. 35730-78-0. Pack Sizes: 10 mg. Product ID: B0005-479861. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyproheptadine Impurities | Cyproheptadine Impurities, critical components in biomedical scrutiny, underpin the rigorous purity and safety assessments of cyproheptadine-centric pharmaceutical formulations. Their pertinence spans allergy mitigation, headache relief, and appetite regulation, ensuring therapeutic effectiveness and adherence to regulatory mandates, thus fortifying pharmacological integrity in clinical practices. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyproterone Impurities | Cyproterone Impurities are crucial reference standards in the biomedical industry for quality control and pharmacokinetic studies of cyproterone acetate, a drug used in treating prostate cancer and managing androgen-related disorders. Utilizing these impurities aids in ensuring drug purity, safety, and consistency in therapeutic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ((Cys31,Nva34)-Neuropeptide Y (27-36))2 | A potent Neuropeptide Y Y5 receptor agonist. Group: Pharmaceutical. CAS No. 172997-92-1. Pack Sizes: 1 mg. Product ID: BAT-006094. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (Cys(S)²)-Octreotide trifluoroacetate salt | Trisulfide Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-449815. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cysteine Impurities | Cysteine Impurities occupy a vital niche in the biomedical arena, integral to the assessment and regulation of pharmaceutical formulation fidelity. Their significance is profound for drug stability and efficacy, notably scrutinized in cysteine-enriched therapies such as cystinuria interventions and N-acetylcysteine applications, augmenting our comprehension of pharmacological dynamics. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cysteinyl-3M3SH | Cysteinyl-3M3SH is an intermediate in the bacterial biotransformation of the odourless physiological malodour precursor Cys-Gly-3M3SH. Cys-Gly-3M3SH is actively transported by the di-/tri-peptide transporter (DtpT) along with the movement of protons. Once inside the cell the terminal glycine is cleaved by a dipeptidase (PepA) to release Cys-3M3SH. Group: Pharmaceutical. Pack Sizes: 250 mg. Product ID: BAT-014377. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cystine Impurities | Cystine Impurities hold a pivotal role in the biomedical sector, crucial for assessing quality and purification in cysteine-based therapeutics. These impurities bear significant impact on drug synthesis and efficacy, particularly for conditions like cystinuria and amino acid metabolic disorders, underscoring the importance of accurate identification and control for therapeutic safety and efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cystofur Impurities | Cystofur Impurities, integral to pharmaceutical exploration, play a crucial role in the refinement and enhancement of cefuroxime, an antibiotic targeting bacterial maladies including respiratory, urinary, and dermal infections. Their examination is pivotal for discerning the safety and efficacy parameters of the drug throughout the development continuum. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CYT-1010 | CYT-1010 is a μ-opioid receptor agonist found in patent WO2013173730A2. Group: Pharmaceutical. CAS No. 213769-33-6. Pack Sizes: 5 mg. Product ID: BAT-006236. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cyt387 | Cyt387 is an ATP-competitive inhibitor of JAK1 and JAK2 (IC50 = 11 nM and 18 nM respectively). It has been shown to decrease cancer stem cell associated tumor burden in a mouse model of human ovarian cancer. It is commonly used as a therapy for myelofibrosis. Uses: An orally bioavailable small-molecule inhibitor of janus kinases 1 and 2 (jak1/2) with potential antineoplastic activity (ic50s = 11 and 18 nm, respectively). Group: Pharmaceutical. CAS No. 1056634-68-4. Pack Sizes: 50 mg. Product ID: B0084-307720. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cytarabine Impurities | Cytarabine Impurities are crucial in the biomedical industry for ensuring the quality and effectiveness of cytarabine, a chemotherapy drug primarily used to treat leukemia and lymphomas. By identifying and quantifying these impurities, researchers enhance drug safety and efficacy, facilitating therapeutic advancements in oncology. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cytidine Impurities | Cytidine Impurities, integral to biomedical pursuits, serve a critical role in assessing and synthesizing nucleoside-derived pharmaceuticals. These impurities are indispensable in antiviral and oncology research, enhancing comprehension of drug purity and efficacy, thus aiding in deciphering therapeutic interventions against disease progression. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cytisine | Cytisine is a nicotinic acetylcholine receptor (nAChR) agonist. It has been used medically to help with smoking cessation. Cytisine can be used in health products. Uses: Smoking cessation. Group: Pharmaceutical. CAS No. 485-35-8. Pack Sizes: 5 g. Product ID: NP0545. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cytosine Impurities | Cytosine Impurities are indispensable to the biomedical domain, crucial for assuring the purity and safety of pharmaceuticals, especially in nucleoside analog synthesis. Engaged in treating leukemia and viral infections, these impurities refine production processes, thereby augmenting the therapeutic efficacy of both antineoplastic and antiviral compounds. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CZ415 | CZ415 is a highly selective potent mTOR inhibitor with little activity on other lipid and protein kinases with efficacy in a collagen induced arthritis model and exhibits excellent cell permeability. In the issue, Bergamini et al., who has identified CZ415, confirmed with its extraordinary selectivity, drug-like properties and proven efficacy in vivo, CZ415 represents an ideal molecule for the pharmacological investigation of mTOR pathophysiological role in vivo. Assessed in dose response format from HEK293T cells after treatment with CZ415: 1. inhibition of S6RP (downstream of mTORC1) phosphorylation in HEK293T: IC50 = 14.5 nM; 2. inhibition of Akt (mTORC2 substrate) phosphorylation in HEK293T: IC50 = 14.8 nM; 3. inhibition of IFNγ release in stimulated human whole blood: IC50 = 226 nM. Group: Pharmaceutical. CAS No. 1429639-50-8. Pack Sizes: 5 mg. Product ID: B0084-474821. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS | DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS. Group: Pharmaceutical. CAS No. 730985-86-1. Pack Sizes: 5 mg. Product ID: BAT-014236. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran | Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. Uses: Benzimidazoles; beta-alanine/analogs & derivatives. Group: Pharmaceutical. CAS No. 211914-51-1. Pack Sizes: 250 mg. Product ID: B0084-102023. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran etexilate | Dabigatran etexilate(BIBR-1048) is the orally active prodrug of dabigatran; Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM. Uses: Antithrombins. Group: Pharmaceutical. CAS No. 211915-06-9. Pack Sizes: 1 g. Product ID: NP3527. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Etexilate Impurity 1 | An impurity of Dabigatran Ethyl Ester, a nonpeptide, direct thrombin inhibitor. Group: Pharmaceutical. CAS No. 1610758-19-4. Pack Sizes: 50 mg. Product ID: B2694-469642. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Etexilate Impurity 2 | O-(2-Ethylbutyl) Dabigatran Ethyl Ester is an impurity of Dabigatran Ethyl Ester, a nonpeptide, direct thrombin inhibitor. Group: Pharmaceutical. CAS No. 1610758-20-7. Pack Sizes: 10 mg. Product ID: B2694-469643. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran etexilate mesylate | Dabigatran etexilate mesylate is the orally active prodrug of dabigatran. It is a reversible and selective, direct thrombin inhibitor (DTI). Group: Pharmaceutical. CAS No. 872728-81-9. Pack Sizes: 2 g. Product ID: B0084-461975. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Etexilate N-Oxide Inner Salt | Dabigatran Etexilate N-Oxide is a metabolite of Dabigatran Etexilate, an oral anticoagulant and direct thrombin inhibitor. Group: Pharmaceutical. CAS No. 1381757-44-3. Pack Sizes: 5 mg. Product ID: B2694-469624. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran ethyl AcOH Salt | Dabigatran ethyl AcOH Salt, a remarkable pharmaceutical compound, plays a pivotal role in studying blood clots, encompassing deep vein thrombosand pulmonary embolism. It exerts its profound anticoagulant effects through targeted inhibition of thrombin, a pivotal enzyme in the intricate clotting cascade. Group: Pharmaceutical. CAS No. 1188263-64-0. Pack Sizes: 50 mg. Product ID: B0043-284782. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran ethyl ester hydrochloride | A derivative of Dabigatran, which acts as a non-peptide, direct thrombin inhibitor. Group: Pharmaceutical. CAS No. 211914-50-0. Pack Sizes: 100 mg. Product ID: B2694-469638. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Impurities | Dabigatran Impurities, crucial constituents within pharmaceutical exploration, play an indispensable role in affirming the quality and safety standards of the anticoagulant dabigatran. Their scrutiny is vital for optimizing formulation, stability, and efficacy, particularly in stroke prophylaxis and deep vein thrombosis, thereby advancing the strategies for managing thromboembolic disorders. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran impurity 002 | An impurity of Dabigatran. Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338809. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran impurity 004 | An impurity of Dabigatran. Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338811. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran impurity 005 | An impurity of Dabigatran. Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: B2694-338812. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran impurity 006 | An impurity of Dabigatran. Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338813. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Impurity 20 | An impurity of Dabigatran. Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. Group: Pharmaceutical. CAS No. 1408238-39-0. Pack Sizes: 5 mg. Product ID: B2694-338808. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Impurity 50 | An impurity of Dabigatran. Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of activity. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338810. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Impurity E | O-(2-Heptyl) Dabigatran Ethyl Ester is an impurity of Dabigatran Ethyl Ester, a nonpeptide, direct thrombin inhibitor. Group: Pharmaceutical. CAS No. 1610758-21-8. Pack Sizes: 10 mg. Product ID: B2694-469631. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dabigatran Impurity H | Des-(N-2-pyridyl-β-alanine ethyl ester) Dabigatran etexilate 5-ethyl carboxylate is a derivative of Dabigatran, an oral thrombin inhibitor used to prevent venous thromboembolism. Group: Pharmaceutical. CAS No. 1408238-36-7. Pack Sizes: 10 mg. Product ID: B0043-469632. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.